EASTON, Md., July 27, 2023 /PRNewswire/ Shore Bancshares, Inc. reported net income of $4.018 million or $0.20 per diluted common share for the second quarter of 2023, compared to net income of.
Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Shore Bancshares, Inc. (NASDAQ: SHBI) (the "Company") reported net income of $7.499 million or $0.38 per diluted common share for the second.
/PRNewswire/ Shore Bancshares, Inc. (NASDAQ: SHBI) (the "Company") reported net income of $7.499 million or $0.38 per diluted common share for the second.
/PRNewswire/ Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies.